Science Explorer Back to mapMap
Discussion
Researcher · Jiangmen Central Hospital · China

Shengshan Xu

Shengshan Xu publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Cancer Immunotherapy and Biomarkers, Cancer, Hypoxia, and Metabolism and Ferroptosis and cancer prognosis.

ORCID 0000-0003-3371-7780 OpenAlex
World rank
#299,279
of 7,710,434 ranked researchers
Rank in China
#32,977
of 978,568
Works
26
Citations
615
Citations per work
23.7
h-index
14
i10-index 16Top 55% in Molecular Biology
Shengshan Xu

What does Shengshan Xu research?

Shengshan Xu's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (8%).

Life Sciences: 10 works · 37.3% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 29.3% of their workMolecular Biology: 4 works · 17.3% of their workCancer Research: 3 works · 12.0% of their workImmunology and Microbiology: 2 works · 8.0% of their workImmunology: 2 works · 8.0% of their workHealth Sciences: 9 works · 36.0% of their workMedicine: 9 works · 36.0% of their workOncology: 4 works · 16.0% of their workPulmonary and Respiratory Medicine: 4 works · 16.0% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 4.0% of their workEverything else: 7 works · 26.7% of their workTHEIR WORKShengshan Xu26works
Life Sciences37%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology829.3%
    2. Immunology and Microbiology28.0%
    1. Medicine936.0%
  3. Everything else726.7%
  1. 1Molecular Biology17% of their works
  2. 2Pulmonary and Respiratory Medicine16% of their works
  3. 3Oncology16% of their works
  4. 4Cancer Research12% of their works
  5. 5Immunology8% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Shengshan Xu's research?

The keywords of their largest research topics: Tumor Microenvironment, Cancer, Gene Expression, Immune Checkpoint Blockade, PD-1 and PD-L1, Cell Death, Ferroptosis and HIF-1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Tumor Microenvironment163 topics
  2. Cancer103 topics
  3. Gene Expression82 topics
  4. Immune Checkpoint Blockade61 topic
  5. PD-1 and PD-L161 topic
  6. Cell Death51 topic
  7. Ferroptosis51 topic
  8. HIF-151 topic
  9. Warburg Effect51 topic
  10. RNA methylation41 topic
  11. m6A-seq41 topic
  12. Activation31 topic
  13. EGFR Mutations31 topic
  14. Macrophage31 topic
  15. Single-Cell31 topic
  16. Targeted Therapy31 topic
  17. Transcriptomics31 topic
  18. Long Noncoding RNAs21 topic
  19. RNA Regulation21 topic

Where does Shengshan Xu work?

Shengshan Xu's main affiliation in the publication record is Jiangmen Central Hospital, China.

How many publications and citations does Shengshan Xu have?

OpenAlex counts 26 works and 615 citations for Shengshan Xu, an h-index of 14, ranking #299,279 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Shengshan Xu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.